Solid lipid Lyo-Nanosuspension: A promising stabilized oral delivery system for the antihyperglycemic extract of mistletoe Plicosepalus acacia

• Published in: Saudi pharmaceutical journal Vol. 31; no. 8; p. 101689
• Main Authors: Zuhair Alshawwa, Samar, Salah Labib, Gihan, Badr-Eldin, Shaimaa M., Ahmed Kassem, Abeer
• Format: Journal Article
• Language: English
• Published: Saudi Arabia Elsevier B.V 01.08.2023; Elsevier
• Subjects: Antihyperglycemic; Dry Solid Lipid; Lyophilized; Nanosuspension; Original; Plicosepalus acaciae extract; Nanosuspension; Dry Solid Lipid; Plicosepalus acaciae extract; Lyophilized; Antihyperglycemic
• ISSN: 1319-0164; 2213-7475
• DOI: 10.1016/j.jsps.2023.06.022

The antihyperglycemic effect of Plicosepalus acaciae (P. acaciae) extract was proven, but it still needs to be formulated into a suitable dosage form. We aimed at preparing an oral stabilized SLNs for P. acaciae with high payload, to be used as powder for reconstitution, filled into capsule or compressed into tablet. SLNs were prepared by emulsion solvent evaporation technique. Preliminary characterization was performed followed by full assessment of the optimized SLNs suspension and/or its lyophilized form: particle size, zeta potential, surface morphology, percentage entrapment efficiency (% EE), DSC, FTIR and in vitro release studies. The optimized SLNs lyophilized formula (F3L) exhibited acceptable compressibility and flowability. The reconstituted F3L showed % sedimentation volume of 91.83 %, re-dispersibility of 95%, viscosity of 764.33 cp, uniform particle size of 30.28 nm as shown by TEM, polydispersity index (PDI) of 0.16, zeta potential of −36.4 mV, % EE of 89.64 % and drug content of 97.69 %. The physical mixture and F3L FTIR spectrum indicated compatibility of components. In vitro release study showed a burst release in lyophilized formulations followed by slow-release, calculated as total phenolic content. Our previously reported work revealed that the total extracts of P. acaciae and SLNs formulations with the greatest lipid content F3s, demonstrated a considerable blood glucose-lowering effect in diabetic rats. The obtained lyophilized SLNs is promising for preparation of a suitable stable dosage form for P. acaciae extract to be used in treatment of diabetes.